Archimedes Development Limited
Records under this name other than patents Archimedes Development Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Archimedes Development Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,491,932 | Compositions for the oral delivery of corticosteroids Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US D663,943 | Child resistant container Formerly held Term ended Term ended Jul 24, 2026 · From the USPTO record | Term ended | Term ended Jul 24, 2026 | From the USPTO record |
| US 9,731,869 | Container Formerly held Lapsed on the fee record Ended Aug 15, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 15, 2025 | From the USPTO record |
| US 8,216,604 | Method of Managing or Treating Pain Formerly held Lapsed on the fee record Ended Jul 10, 2024 · High confidence | Lapsed on the fee record | Ended Jul 10, 2024 | High confidence |
| US 9,814,705 | Intranasal Spray Device Containing Pharmaceutical Composition Formerly held Term ended Term ended Jan 8, 2024 · High confidence | Term ended | Term ended Jan 8, 2024 | High confidence |
| US 9,078,814 | Intranasal Spray Device Containing Pharmaceutical Composition Formerly held Lapsed on the fee record Ended Jul 14, 2023 · High confidence | Lapsed on the fee record | Ended Jul 14, 2023 | High confidence |
| US 8,915,393 | Child resistant container Lapsed on the fee record Ended Dec 23, 2022 · From the USPTO record | Lapsed on the fee record | Ended Dec 23, 2022 | From the USPTO record |
| US 8,889,176 | Method of Managing or Treating Pain Formerly held Lapsed on the fee record Ended Nov 18, 2022 · High confidence | Lapsed on the fee record | Ended Nov 18, 2022 | High confidence |
| US 8,481,070 | Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof Lapsed on the fee record Ended Jul 9, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jul 9, 2021 | From the USPTO record |
| US 8,309,108 | Intranasal compositions Lapsed on the fee record Ended Nov 13, 2020 · From the USPTO record | Lapsed on the fee record | Ended Nov 13, 2020 | From the USPTO record |